Federal contract market · NAICS 325412
Pharmaceutical Preparation Manufacturing (NAICS 325412): Federal Contract Market
Data through 2026-10-26 · FY2027 to date
- Obligations, FY2027 to date
- $84.2M
- Contract awards
- 373
- Average award size
- $226K
- vs. prior full fiscal year
- 99.4% decline
| Item | Obligations |
|---|---|
| FY22 | $34.4B |
| FY23 | $12.8B |
| FY24 | $10.1B |
| FY25 | $13.1B |
| FY26 | $14.5B |
| FY27 | $84.2M |
Obligations fell 99.4% year over year, from $14.5B in FY2026 to $84.2M in FY2027 to date.
Pharmaceutical Preparation Manufacturing (NAICS 325412) contracted much less federal work in FY2027 to date than in prior years. The federal government obligated $84.2M in FY2027 to date through 373 awards, with an average award size of $226K. Obligations fell down 99.4% year over year. The fiscal-year series shows much larger totals earlier in the decade: FY22 $34.4B, FY23 $12.8B, FY24 $10.1B, FY25 $13.1B, FY26 $14.5B, and FY27 $84.2M. The Department of Veterans Affairs is the largest buyer for the period and a handful of vendors account for a large share of obligations. The award count and average award size suggest many smaller transactions in FY2027 to date compared with prior fiscal years that reported much larger totals. The mix of buyers and vendors in FY2027 to date highlights concentration around medical supply and specialty pharmaceutical contractors and a marked drop in overall federal spending on this NAICS code.
Which agencies are buying NAICS 325412 in FY2027 to date?
The Department of Veterans Affairs obligated $69.6M in FY2027 to date, followed by the Department of Justice with $14.6M. The Department of State recorded $0 for the period. Agency-level variation is large compared with the sector total of $84.2M.
| Item | Obligations |
|---|---|
| Department of Veterans Affairs | $69.6M |
| Department of Justice | $14.6M |
| Department of State | $0 |
| Department of Commerce | -$319 |
Department of Veterans Affairs was the top buyer, obligating $69.6M (82.7% of all obligations).
Who are the largest vendors in FY2027 to date?
CARDINAL HEALTH 414, LLC obligated $15M and MCKESSON CORPORATION obligated $14.5M in FY2027 to date. PROGENICS PHARMACEUTICALS INC obligated $12.1M and NOVARTIS PHARMACEUTICALS CORPORATION obligated $8.4M. The top ten vendors together concentrate a substantial share of the $84.2M total.
| Item | Obligations |
|---|---|
| CARDINAL HEALTH 414, LLC | $15M |
| MCKESSON CORPORATION | $14.5M |
| PROGENICS PHARMACEUTICALS INC | $12.1M |
| NOVARTIS PHARMACEUTICALS CORPORATION | $8.4M |
| OPTUM INFUSION SERVICES 308, LLC | $4.9M |
| EXELAN PHARMACEUTICALS INC | $3.3M |
| TELIX PHARMACEUTICALS US INC | $2.4M |
| JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. | $2.4M |
| PETNET SOLUTIONS, INC. | $2.3M |
| SOFIE CO. | $2.3M |
CARDINAL HEALTH 414, LLC led all vendors with $15M in obligations, 17.9% of the market.
| Rank | Vendor | Obligations |
|---|---|---|
| 1 | CARDINAL HEALTH 414, LLC | $15M |
| 2 | MCKESSON CORPORATION | $14.5M |
| 3 | PROGENICS PHARMACEUTICALS INC | $12.1M |
| 4 | NOVARTIS PHARMACEUTICALS CORPORATION | $8.4M |
| 5 | OPTUM INFUSION SERVICES 308, LLC | $4.9M |
| 6 | EXELAN PHARMACEUTICALS INC | $3.3M |
| 7 | TELIX PHARMACEUTICALS US INC | $2.4M |
| 8 | JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. | $2.4M |
| 9 | PETNET SOLUTIONS, INC. | $2.3M |
| 10 | SOFIE CO. | $2.3M |
| Rank | Recipient | Award Amount | Awarding Agency |
|---|---|---|---|
| 1 | SOFIE CO. | $5.1M | Department of Veterans Affairs |
| 2 | NOVARTIS PHARMACEUTICALS CORPORATION | $4.3M | Department of Veterans Affairs |
| 3 | NOVARTIS PHARMACEUTICALS CORPORATION | $4.1M | Department of Veterans Affairs |
| 4 | CARDINAL HEALTH 414, LLC | $3.9M | Department of Veterans Affairs |
| 5 | BOSTON SCIENTIFIC CORP | $3.8M | Department of Veterans Affairs |
| 6 | PROGENICS PHARMACEUTICALS INC | $3.8M | Department of Veterans Affairs |
| 7 | CLINICAL PHARMACY SERVICES, INC. | $3.2M | Department of Veterans Affairs |
| 8 | EXELAN PHARMACEUTICALS INC | $3.1M | Department of Veterans Affairs |
| 9 | CARDINAL HEALTH 414, LLC | $3.1M | Department of Veterans Affairs |
| 10 | PROGENICS PHARMACEUTICALS INC | $2.7M | Department of Veterans Affairs |
| 11 | EXELAN PHARMACEUTICALS INC | $2.5M | Department of Veterans Affairs |
| 12 | RLS (USA) INC. | $2.1M | Department of Veterans Affairs |
| 13 | MCKESSON CORPORATION | $2M | Department of Justice |
| 14 | CARDINAL HEALTH 414, LLC | $2M | Department of Veterans Affairs |
| 15 | OPTUM INFUSION SERVICES 308, LLC | $1.9M | Department of Veterans Affairs |
| 16 | NOVARTIS PHARMACEUTICALS CORPORATION | $1.9M | Department of Veterans Affairs |
| 17 | PETNET SOLUTIONS, INC. | $1.9M | Department of Veterans Affairs |
| 18 | PROGENICS PHARMACEUTICALS INC | $1.7M | Department of Veterans Affairs |
| 19 | PROGENICS PHARMACEUTICALS INC | $1.6M | Department of Veterans Affairs |
| 20 | EXELAN PHARMACEUTICALS INC | $1.5M | Department of Veterans Affairs |
| 21 | TELIX PHARMACEUTICALS US INC | $1.5M | Department of Veterans Affairs |
| 22 | NOVARTIS PHARMACEUTICALS CORPORATION | $1.3M | Department of Veterans Affairs |
| 23 | RLS (USA) INC. | $1.3M | Department of Veterans Affairs |
| 24 | NOVARTIS PHARMACEUTICALS CORPORATION | $1.3M | Department of Veterans Affairs |
| 25 | PROGENICS PHARMACEUTICALS INC | $1.3M | Department of Veterans Affairs |
| Rank | Contract | Incumbent | Award Value | Awarding Agency | Ends |
|---|---|---|---|---|---|
| 1 | HHSO100201700019C | BAVARIAN NORDIC A/S | $1.3B | Department of Health and Human Services | 2027-09-26 |
| 2 | 75A50120C00092 | PHLOW CORP. | $697M | Department of Health and Human Services | 2027-01-13 |
| 3 | 75A50119C00037 | EMERGENT BIOSOLUTIONS CANADA INC | $422M | Department of Health and Human Services | 2027-03-30 |
| 4 | 75A50119C00075 | EMERGENT BIOSOLUTIONS CANADA INC | $321M | Department of Health and Human Services | 2027-03-30 |
| 5 | 75A50325F80013 | ALVOGEN, INC. | $228M | Department of Health and Human Services | 2027-06-29 |
| 6 | 75D30123C17978 | MCKESSON SPECIALTY DISTRIBUTION LLC | $204M | Department of Health and Human Services | 2027-01-31 |
| 7 | 75A50325F80009 | CHARTWELL RX LLC | $145M | Department of Health and Human Services | 2027-06-22 |
| 8 | 75A50323F80027 | PARTNER THERAPEUTICS, INC. | $134M | Department of Health and Human Services | 2027-03-29 |
| 9 | 75N98026C00026 | DLA TROOP SUPPORT | $77.4M | Department of Health and Human Services | 2027-04-09 |
| 10 | 75A50325F80014 | EXELAN PHARMACEUTICALS INC | $74.1M | Department of Health and Human Services | 2027-06-29 |
| 11 | 75A50325F80036 | GENENTECH USA, INC | $37.5M | Department of Health and Human Services | 2027-09-29 |
| 12 | 75A50325C00020 | RAFA LABORATORIES LTD | $33.4M | Department of Health and Human Services | 2027-09-29 |
| 13 | 75A50326F80004 | USANTIBIOTICS LLC | $30M | Department of Health and Human Services | 2027-05-28 |
This is the free layer.
GovHub customers get the live version, filters, exports, and AI proposal drafting on top of this data.
No credit card required · 14-day free trial
Frequently asked questions
How much does the federal government spend on NAICS 325412?
The federal government obligated $84.2M on NAICS 325412 in FY2027 to date. The FY2027 to date total comes from 373 awards with an average award size of $226K, and obligations fell down 99.4% year over year. Prior fiscal years were larger: FY22 $34.4B, FY23 $12.8B, FY24 $10.1B, FY25 $13.1B, FY26 $14.5B.
Which agencies buy the most NAICS 325412 services?
The Department of Veterans Affairs and the Department of Justice are the largest buyers in FY2027 to date. The Department of Veterans Affairs obligated $69.6M and the Department of Justice obligated $14.6M. The Department of State recorded $0 for the period.
Who are the largest NAICS 325412 government contractors?
CARDINAL HEALTH 414, LLC and MCKESSON CORPORATION are the largest contractors in FY2027 to date. CARDINAL HEALTH 414, LLC obligated $15M and MCKESSON CORPORATION obligated $14.5M. Other top vendors include PROGENICS PHARMACEUTICALS INC $12.1M and NOVARTIS PHARMACEUTICALS CORPORATION $8.4M.
Found your market? GovHub writes the proposal.
Turn this market intelligence into a submitted, compliant federal proposal, faster.
No credit card required · 14-day free trial